What is it?

EXM is an extracellular-matrix allograft derived from perinatal birth tissues (umbilical cord and placental membranes) donated after healthy, full-term deliveries. This tissue matrix contains collagens I, III, IV, V, VI, VII, growth factors, hyaluron, fibronectin and other key proteins and biologic components which are known to support optimal conditions in the body.

How is it sourced?

Exclusively from rigorously screened, healthy donors in Utah, United States, following live, full-term births. All donors undergo lifestyle, medical, and three-generation genetic screening. Tissue is collected within hours of birth, processed in an FDA-registered HCT/P establishment in compliance with 21 CFR Part 1271 (CGTP).

Advantages 

• Highly qualified female donors.
• Highest level screening and testing of tissue and processing re-agents.
• State-of-the-art FDA registered processing facility.
• Team with 50 years combined experience in the HCT/P market.

Regenerative Research Group’s proprietary method of processing and preservation does not change the essential properties of structural tissue. This is necessary for its use in structure, cushioning, and support. The process preserves the biological traits of the source material. Their proprietary process begins with meticulous screening of the donor mother and father, as well as family members across multiple generations, to identify qualified candidates.